| FDIKX | RERFX | FDIKX / RERFX | |
| Total Expense Ratio | 0.51 | 0.52 | 98% |
| Annual Report Gross Expense Ratio | 0.51 | 0.52 | 98% |
| Fund Existence | 18 years | 24 years | - |
| Gain YTD | 23.490 | 21.543 | 109% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 13.3B | 134B | 10% |
| Annual Yield % from dividends | 1.68 | 0.84 | 200% |
| Returns for 1 year | 16.47 | 12.77 | 129% |
| Returns for 3 years | 41.20 | 30.61 | 135% |
| Returns for 5 years | 18.44 | 3.71 | 497% |
| Returns for 10 years | 54.47 | 44.17 | 123% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XDQQ | 39.45 | 0.32 | +0.81% |
| Innovator Gr 100 Acltd ETF™ Quarterly | |||
| IBGA | 25.01 | 0.03 | +0.10% |
| iShares iBonds Dec 2044 Term Trsy ETF | |||
| USNZ | 41.83 | N/A | N/A |
| Xtrackers Net Zero Pwy Par Alg US Eq ETF | |||
| INFL | 43.51 | -0.41 | -0.93% |
| Horizon Kinetics Inflation Bnfcrs ETF | |||
| LFSC | 36.62 | -0.61 | -1.64% |
| F/m Emerald Life Sciences Innovation ETF | |||